Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Masliah-Planchon

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
La Revue De Medecine Interne|November 22, 2011
[Antiphospholipid antibodies and haemostasis]J Masliah-Planchon, L Darnige
Annales De Biologie Clinique|August 30, 2008
[Review: delta-storage pool disease]J Masliah-Planchon, C Flaujac, J Tapon-Bretaudière, et al.
Gynecologic Oncology Reports|September 20, 2021
Tumor <i>BRCA</i> testing can reveal a high tumor mutational burden related to <i>POLE</i> pathogenic variantsM-C Villy, J Masliah-Planchon, S Melaabi, et al.
Cancer Biomarkers : Section a of Disease Markers|February 22, 2020
Loss of SMARCB1 expression in colon carcinomaS Melloul, J-F Mosnier, J Masliah-Planchon, et al.
Journal of Medical Genetics|April 16, 2009
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotypeE Pasmant, A Sabbagh, N Hanna, et al.
Neuropathology and Applied Neurobiology|January 6, 2017
Rhabdoid component emerging as a subclonal evolution of paediatric glioneuronal tumoursA Bertrand, C Rondenet, J Masliah-Planchon, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2019
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular TargetsA Moreira, J Masliah-Planchon, C Callens, et al.
ESMO Open|June 12, 2021
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgeryA Moreira, A Poulet, J Masliah-Planchon, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classificationK Rahmani Narj Abadi, C Dupain, I Guillou, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
La Revue De Medecine Interne|November 22, 2011
[Antiphospholipid antibodies and haemostasis]J Masliah-Planchon, L Darnige
Annales De Biologie Clinique|August 30, 2008
[Review: delta-storage pool disease]J Masliah-Planchon, C Flaujac, J Tapon-Bretaudière, et al.
Gynecologic Oncology Reports|September 20, 2021
Tumor <i>BRCA</i> testing can reveal a high tumor mutational burden related to <i>POLE</i> pathogenic variantsM-C Villy, J Masliah-Planchon, S Melaabi, et al.
Cancer Biomarkers : Section a of Disease Markers|February 22, 2020
Loss of SMARCB1 expression in colon carcinomaS Melloul, J-F Mosnier, J Masliah-Planchon, et al.
Journal of Medical Genetics|April 16, 2009
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotypeE Pasmant, A Sabbagh, N Hanna, et al.
Neuropathology and Applied Neurobiology|January 6, 2017
Rhabdoid component emerging as a subclonal evolution of paediatric glioneuronal tumoursA Bertrand, C Rondenet, J Masliah-Planchon, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2019
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular TargetsA Moreira, J Masliah-Planchon, C Callens, et al.
ESMO Open|June 12, 2021
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgeryA Moreira, A Poulet, J Masliah-Planchon, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classificationK Rahmani Narj Abadi, C Dupain, I Guillou, et al.
Pageof 1